Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Immunomedics and UCB amend epratuzumab license agreement

Dec. 29, 2011

ProteoTech and GSK enter agreement

Dec. 28, 2011

Karo Bio and Pfizer to jointly develop new drugs for autoimmune diseases

Dec. 28, 2011

Japan Tobacco and Gilead Sciences enter licensing agreement

Dec. 28, 2011

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Dec. 23, 2011

Affibody and Nuclisome join forces to develop cancer therapeutics

Dec. 23, 2011

NewGen Therapeutics acquires targeted oncology programs

Dec. 22, 2011

AbGenomics to regain rights to immunotherapeutic for psoriasis and other immunological diseases

Dec. 22, 2011

Hanmi and Kinex sign Orascovery licensing agreement

Dec. 22, 2011

Merck & Co. and Roche begin clinical collaboration for HCV infection

Dec. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...